TransMedics Group, Inc. is 1.2x more valuable than Axogen, Inc. by market capitalization ($2.58 B vs $2.19 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | AXGN | TMDX |
|---|---|---|
| Market cap | $2.19 B | $2.58 B |
| US-listed rank | #2038 | #1919 |
| Revenue (latest FY) | $225.21M | $605.49M |
| Net income (latest FY) | -$15.70M | $190.30M |
| Net margin | -7.0% | 31.4% |
| P/E (trailing FY) | - | 13.6 |
| SEC filings | 1,334 | 615 |
TransMedics Group, Inc. is 1.2x more valuable than Axogen, Inc. by market capitalization ($2.58 B vs $2.19 B).
In their latest fiscal years, Axogen, Inc. reported $225.21M in revenue while TransMedics Group, Inc. reported $605.49M.
Full pages: Axogen, Inc. and TransMedics Group, Inc., or browse the full rankings.